Dr. Goldstein’s research interests include novel therapeutics in Fontan circulation, myocardial fibrosis and diastolic dysfunction, transcatheter valve therapies and device trials in pediatric and congenital interventional cardiology. He is co-founder and vice president of the Congenital Cardiac Research Collaborative, a robust multi-center congenital cardiac registry, using data from the leading centers in North America to develop benchmarks in long-term outcomes, improve care and introduce innovative therapies for congenital heart disease patients.
Dr. Goldstein earned his medical degree from Boston University School of Medicine, followed by his internship and residency in pediatrics at Children's Hospital Boston and Boston Medical Center. He then completed a fellowship in pediatric cardiology and an advanced fellowship in pediatric interventional catheterization at C.S. Mott Children's Hospital in Ann Arbor, Michigan. Upon completing his training, Dr. Goldstein was recruited to join the faculty at the University of Cincinnati College of Medicine, where he rose in the ranks to associate professor of pediatrics and associate director of cardiac catheterization and intervention at Cincinnati Children's Hospital before being recruited to UPMC in 2019.
Dr. Goldstein is a fellow of the American Academy of Pediatrics, the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. He has published over 100 peer-reviewed manuscripts and sits on the editorial advisory board of Pediatric Cardiology. Dr. Goldstein has received research funding from the National Heart, Lung, and Blood Institute and the American Heart Association, serves as the principal investigator for many clinical trials and has mentored numerous pediatric cardiology trainees throughout his career.
